INJECTIS
ActiveSummary
INJECTIS has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €955,149 and a net result of €284,497. Equity is growing by about 41% per year across the filed financial years. Its solvency ranks better than 73% of 106 sector peers (NACE 39, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
11-02
Gazette deed
Resignation: Jeroen Vandenbruwane (director)Appointment: VaViTech bv (director) · Permanent representative: Jeroen Vandenbruwane · Director discharge6 facts ▸
- General meeting, 23-12-2025
- Director resignation, Jeroen Vandenbruwane (director (not named in the articles))
- Director discharge, Jeroen Vandenbruwane (director (not named in the articles))
- Director appointment, VaViTech bv (director (not named in the articles))
- Permanent representative, Jeroen Vandenbruwane
- Declaration, “kennis genomen van en akkoord met de benoeming door de rechtspersoon VaViTech bv van Jeroen Vandenbruwane als vaste vertegenwoordiger” (deed in Dutch)
Show earlier events
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.